Skip to main content
SpringerLink
Log in

High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

In the present study we compared the levels of CA-125, CA 19-9, and CA 15-3 in the peritoneal fluid (PF) of patients with and without endometriosis, then assessed the possibility of a correlation among these tumor markers.

Study design

Our study was a controlled clinical study of patients undergoing laparoscopy for infertility or other benign gynecology conditions. Peritoneal fluid samples were collected from 65 women with endometriosis and 43 women without pelvic disease. Levels of CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid were determined by immunoradiometric assay.

Results

The concentration of CA-125 in PF from patients with endometriosis was significantly higher than that in the control group (p<0.001); for CA 19-9 and CA 15-3, PF concentrations were not statistically different between these two groups. Women with endometriosis had significantly higher levels of CA-125 in proliferative and secretory phases than the control group (p<0.001 and p<0.002 respectively); furthermore, in patients with endometriosis the CA 19-9 levels were significantly lower in secretory phase than the proliferative (p<0.004). The levels of CA-125 were significantly lower in women with tubal ligation, in comparison with infertility or pelvic pain in the control group (p<0.001). No significant difference was seen in women with infertility or pelvic pain in endometriosis group and the levels of CA-125, CA 19-9, and CA 15-3. We did not find any correlation between the stages of endometriosis and the concentration of CA-125, CA 19-9 and CA 15-3. A significant correlation between the CA 19-9 levels and CA 15-3 in patients with endometriosis was found (r=0.72, p=0.001).

Conclusions

We found high concentrations of CA-125, CA 19-9, and CA 15-3 in the peritoneal fluid of women with and without endometriosis in the Yale series. However, the levels only of CA-125 were higher in women with endometriosis, but without diagnostic value. The role of simultaneously high concentrations of CA 19-9 and CA 15-3 in women with endometriosis needs to be explored further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. American Fertility Society (1985) Revised American Fertility Society classification of endometriosis. Fertil Steril 43:351–352

    PubMed  Google Scholar 

  2. Arici A, Oral E, Attar E, Tazuke SI, Olive DL (1997) Monocyte chemotactic protein-1 concentration in peritoneal fluid in patients with endometriosis and its modulation in human mesothelial cells. Fertil Steril 67:1065–1072

    Article  CAS  PubMed  Google Scholar 

  3. Barbati A, Cosmi EV, Spaziani R, Ventura R, Montanino G (1994) Serum and peritoneal fluid CA-125 levels in patients with endometriosis. Fertil Steril 61:438–442

    CAS  PubMed  Google Scholar 

  4. Barbieri RL, Niloff JM, Bast RC, Schaetzl E, Kistner RW, Knapp RC (1986) Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 45:630–634

    CAS  PubMed  Google Scholar 

  5. Bast RC, Klug TL, John E, Jenison E, Niloff JM, Lazarus H et al (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 300:883–889

    Google Scholar 

  6. Bon GG, Kenemans P, Dekker JJ, Hompes PG, Verstraeten RA, Kamp G-J et al (1999) Fluctuations in CA-125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles. Hum Reprod 14:566–570

    Article  CAS  PubMed  Google Scholar 

  7. Fedele L, Vercellini P, Arcaini L, da Dult MG, Candiani GB (1988) CA-125 in serum, peritoneal fluid, active lesions, and endometrium with patients with endometriosis. Am J Obstet Gynecol 158:166–170

    CAS  PubMed  Google Scholar 

  8. Fisk NM, Tan CE (1988) CA-125 in peritoneal fluid and serum of patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 29:153–158

    CAS  PubMed  Google Scholar 

  9. Gürgan T, Kishisci H, Yarali H, Aksu T, Zeyneloglu H, Develioglu O (1990) Serum and peritoneal fluid CA-125 levels in early stage endometriosis. Gynecol Obstet Invest 30:105–108

    PubMed  Google Scholar 

  10. Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC 125. Int J Gynecol Pathol 2:275–285

    CAS  PubMed  Google Scholar 

  11. Magnani LJ, Steplewski Z, Koprowski H, Ginsburg V (1983) Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43:5489–5497

    CAS  PubMed  Google Scholar 

  12. Matalliotakis I, Makrigiannakis A, Karkavitsas N, Psaroudakis E, Froudarakis G, Koumantakis E (1994) Use of CA-125 in the diagnosis of endometriosis: influence of treatment with danazol. Int J Fertil 39:100–104

    CAS  Google Scholar 

  13. Matalliotakis I, Panidis D, Vlassis G, Neonaki M, Goumenou A, Koumantakis E (1998) Unexpected increase of the CA 19-9 tumour marker in patients with endometriosis. Eur J Gynecol Oncol 5:490–493

    Google Scholar 

  14. Moen MH, Hagen B, Onsrud M (1991) CA-125 in peritoneal fluid from patients with endometriosis. Hum Reprod 6:1400–1403

    CAS  PubMed  Google Scholar 

  15. Mol BW, Bayran N, Lijmer JG, Wiegerinck MA, Bongers MY, Veen F, Bossuyt PM (1998) The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 70:1101–1108

    Article  CAS  PubMed  Google Scholar 

  16. Moretuzzo RW, Chen SL, DiLauro S, Reindollar RH, Jension E, McDonough PG (1988) Serum and peritoneal lavage fluid CA-125 levels in endometriosis. Fertil Steril 50:430–433

    CAS  PubMed  Google Scholar 

  17. Olt G, Berchuck A, Bast R Jr (1990) The role of tumor markers in gynecologic oncology. Obstet Gynecol Surv 45:570–577

    CAS  PubMed  Google Scholar 

  18. Panidis D, Vlassis G, Matalliotakis J, Skiadopoulos S, Kalogeropoulos A (1999) Serum levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 in patients with endometriosis. J Endocrinol Invest 11:801–804

    Google Scholar 

  19. Pittaway DE, Fayez JA (1986) The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril 46:790–795

    CAS  PubMed  Google Scholar 

  20. Suzuki M, Sekiguchi I, Tamada I (1990) Clinical evaluation of tumor-associated mucin-type glycoprotein CA 54/61 in ovarian cancers: comparison with CA-125. Obstet Gynecol 76:422–427

    CAS  PubMed  Google Scholar 

  21. Williams RS, Rao CV, Yussman MA (1988) Interference in the measurement of CA-125 in peritoneal fluid. Fertil Steril 49:547–550

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Dr Arici, Professor and Director of Division of Reproductive Endocrinology and Infertility, at Yale University School of Medicine, New Haven, Connecticut, USA for their important contributions to this manuscript and especially for participation in the collection of peritoneal fluid samples. We thank Dr Mahutte for medical support. We thank the staff of the Department of Nuclear Medicine, University of Crete, Greece, for their technical assistance. This work was generously supported by a grant from the Department of Gynaecology and Obstetrics, University of Crete.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Crete, P.O. Box 1393, 714–9 Heraklion, Crete, Greece

    Ioannis M. Matalliotakis, Anastasia G. Goumenou & Eugenios E. Koumantakis

  2. 7 Giannikou Street, 71201 Heraklion, Crete, Greece

    Ioannis M. Matalliotakis

  3. Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT, USA

    Naciye Mulayim

  4. Department of Nuclear Medicine, University of Crete, Crete, Greece

    Nikolaos Karkavitsas

Authors
  1. Ioannis M. Matalliotakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anastasia G. Goumenou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naciye Mulayim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nikolaos Karkavitsas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eugenios E. Koumantakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ioannis M. Matalliotakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matalliotakis, I.M., Goumenou, A.G., Mulayim, N. et al. High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis. Arch Gynecol Obstet 271, 40–45 (2005). https://doi.org/10.1007/s00404-004-0645-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-004-0645-7

Keywords

Search

Navigation